By contrast, the Dutch study by van den Berg et al. that also revealed a higher IgM seroprevalence (5%) used the same assay as in our study, but included patients diverging with regards to clinical characteristics (patients with classical GBS only). The gene discussed is CD40LG; the disease is Guillain-Barre syndrome.